Archive

Program helps cancer survivors return to work with confidence

Written by Charlie King | 13 Jun 2025

A new pilot project led by McGill University researchers is showing early success in helping cancer survivors return to work, addressing an aspect of recovery they say is… read more.

Popular CT scans could account for 5% of all cancer cases a year

Written by Charlie King | 20 Apr 2025

Radiation from imaging could lead to lung, breast and other future cancers, with 10-fold increased risk for babies CT scans may account for 5% of all cancers annually,… read more.

Muscular strength and good physical fitness linked to lower risk of death in people with cancer

Written by Charlie King | 25 Jan 2025

Muscular strength and good physical fitness are linked to a significantly lower risk of death from any cause in people with cancer, finds a pooled data analysis of… read more.

Specific long term condition combinations have major role in NHS ‘winter pressures’

Written by Charlie King | 17 Nov 2024

Specific combinations of long term conditions have a major role in the additional pressures the NHS faces every winter, because they are associated with significantly higher risks of … read more.

Obesity-related cancer rising sharply in young Chinese people

Written by Gary Finnegan | 5 Sep 2024

Rates of obesity-linked cancers in China rose at an alarming 3.6% every year between 2007 and 2021 while non-obesity-related cancers remained stable, according to new data published in… read more.

One in five people with cancer participate in medical research studies

Written by Charlie King | 5 Apr 2024

Researchers from Fred Hutchinson Cancer Center, the American Cancer Society Cancer Action Network and peer institutions released new findings in the Journal of Clinical Oncology showing that when all types of cancer research studies are… read more.

CHMP recommends subcutaneous injection of Tecentriq for multiple cancer types – Roche

Written by Charlie King | 19 Nov 2023

Roche announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of subcutaneous (SC, or under the skin). Tecentriq (atezolizumab)…. read more.

Artificial intelligence enhances radiotherapy for Henry Ford Health patients with cancer

Written by Charlie King | 10 Nov 2023

Patients undergoing radiation therapy for certain types of cancer at Henry Ford West Bloomfield Hospital are among the first in the country with access to a cutting-edge treatment system that… read more.

Nearly half of oncology drugs approved since 1998 are precision therapies

Written by Charlie King | 20 Oct 2023

Of the 198 new oncology drugs approved by the U.S. Food and Drug Administration (FDA) between 1998 and 2022, approximately 43% were precision oncology therapies, the use of… read more.

Community health van increases access to a vaccine that helps to prevent six types of cancer

Written by Charlie King | 6 May 2023

In a joint initiative that includes Hollings Cancer Center and the Department of Pediatrics, MUSC researchers launched a community mobile health van in 2021 to help to increase… read more.

Study finds “important shortcomings” in official cancer drug information

Written by Charlie King | 10 Apr 2023

Important information about cancer drug benefits, and related uncertainties, is frequently omitted from official prescription drug information sources for clinicians and patients in Europe, finds an analysis published… read more.

Breast MRI effective at detecting cancer in dense breasts

Written by Charlie King | 2 Feb 2023

Compared to other common supplemental screening methods, breast MRI was superior at detecting breast cancer in women with dense breasts, according to a study published in Radiology, a journal… read more.

1 2 3 … 48 Next »

Archive

Subscribe for our mailing list

Follow Us